Products for Research Use Only
RegisterLogin

Edoxaban-d6

CAT: 0804-HY-10264SSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10264SSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Edoxaban-d6 is deuterium labeled Edoxaban. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with Kis of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and can be used for stroke prevention. Edoxaban is also a weak inhibitor of thrombin and factor IXaβ (FIXa), with Kis of 6.00 μM and 41.7 μM, respectively, exhibits >10000-fold selectivity for FXa. Edoxaban has antithrombotic properties and has potential for thromboembolic diseases treatment[1][2][3].
CAS Number
1304701-57-2
Product Name Alternative
DU-176-d6
UNSPSC
12352005
Hazard Statement
H302+H312+H332, H315, H319
Target
Factor Xa; Thrombin
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Purity
99.6
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC2=C(CN(CC2)C)S1)N[C@H]3[C@H](CC[C@@H](C3)C(N(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)NC(C(NC4=CC=C(C=N4)Cl)=O)=O
Molecular Formula
C24H24D6ClN7O4S
Molecular Weight
554.09
Precautions
H302+H312+H332, H315, H319
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Furugohri T, et al. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost. 2008 Sep;6 (9) :1542-9.|[3]Mendell J, Lee F, Chen S, The Effects of the Antiplatelet Agents, Aspirin and Naproxen, on Pharmacokinetics and Pharmacodynamics of the Anticoagulant Edoxaban, a Direct Factor Xa Inhibitor. J Cardiovasc Pharmacol. 2013 Apr 23. [Epub ahead of print]|[4]Stacy ZA, et al. Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism. Cardiol Ther. 2016 Jun;5 (1) :1-18.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-10264-01Edoxaban
HY-10264R-01Edoxaban (Standard)
HY-10264A-01Edoxaban (tosylate)
HY-119124-01Edoxaban M4
HY-10264CEdoxaban (hydrochloride)
HY-Z4764-01Edoxaban impurity 62
HY-Z4757-01Edoxaban impurity 59
HY-Z4767-01Edoxaban impurity 65
HY-Z4762-01Edoxaban impurity 49
HY-Z4765-01Edoxaban impurity 63

Alternative Products

CatalogName
TRC-E555522-5MGEdoxaban-d6
TRC-E555537-25MGEnt-Edoxaban-d6
CS-BU-00125Edoxaban-d6 Hydrochloride
TRC-E555557-25MG1-epi-Edoxaban-d6
AR-E01034-01Edoxaban-d6 (HCl Salt)
RM-E042959-01N-Nitroso Edoxaban-D6
CS-O-60781N-Nitroso Desmethyl Edoxaban-d6
TRC-E555520-50MGEdoxaban

Popular Products